Skip Navigation

European Heart Journal 2002 23(3):223-229; doi:10.1053/euhj.2001.2738
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (96)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Morrow, D.A.
Right arrow Articles by Braunwald, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrow, D.A.
Right arrow Articles by Braunwald, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

D.A. Morrowa,f1, E.M. Antmana, S.M. Snapinnb, C.H. McCabea, P. Therouxc and E. Braunwalda

a Department of Medicine, Brigham and Women's Hospital, Boston, MA, U.S.A.
b Merck & Co. Whitehouse Station, NJ, U.S.A.
c Montreal Heart Institute, Montreal, Canada

revised April 9, 2001; accepted April 11, 2001

Abstract

Aims We evaluated the TIMI Risk Score for Unstable Angina and Non-ST Elevation Myocardial Infarction for predicting clinical outcomes and the efficacy of tirofiban in non-ST elevation acute coronary syndromes.

Methods and Results Developed in TIMI 11B, the risk score is calculated as the sum of seven presenting characteristics (age ≥65 years, ≥3 cardiac risk factors, documented coronary disease, recent severe angina, ST deviation ≥0·5mm, elevated cardiac markers, prior aspirin use). The risk score was validated in the PRISM-PLUS database (n=1915) and tested for interaction with the efficacy of tirofiban+heparin vs heparin alone. The risk score revealed an increasing gradient of risk for death, myocardial infarction or recurrent ischaemia at 14 days ranging from 7·7–30·5% (P<0·001). Dichotomized at the median, patients with a score ≥4 derived a greater relative risk reduction with tirofiban (P(Interaction)=0·025). Among patients with normal creatine kinase myocardial bands, the risk score showed a 3·5-fold gradient of risk (P<0·001) and identified a population that derived significant benefit from tirofiban (RR 0·73,P =0·027).

Conclusion The TIMI Risk Score is a simple clinical tool for risk assessment that may aid in the early identification of patients who should be considered for treatment with potent antiplatelet therapy.

Key Words: coronary disease, prognosis, myocardial infarction, unstable angina, platelet inhibitors

f1 Correspondence: David A. Morrow, MD, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, U.S.A.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mayo Clin Proc.Home page
A. Kumar and C. P. Cannon
Acute Coronary Syndromes: Diagnosis and Management, Part I
Mayo Clin. Proc., October 1, 2009; 84(10): 917 - 938.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. T. Yan, R. T. Yan, T. Huynh, A. Casanova, F. E. Raimondo, D. H. Fitchett, A. Langer, S. G. Goodman, and for the Canadian Acute Coronary Syndrome Registry
Understanding Physicians' Risk Stratification of Acute Coronary Syndromes: Insights From the Canadian ACS 2 Registry
Arch Intern Med, February 23, 2009; 169(4): 372 - 378.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C P Gale, S O M Manda, C F Weston, J S Birkhead, P D Batin, and A S Hall
Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database
Heart, February 1, 2009; 95(3): 221 - 227.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. A. Harrington, R. C. Becker, C. P. Cannon, D. Gutterman, A. M. Lincoff, J. J. Popma, G. Steg, G. H. Guyatt, and S. G. Goodman
Antithrombotic Therapy for Non-ST-Segment Elevation Acute Coronary Syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 670S - 707S.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
American College of Cardiology/American Heart Asso, 2007 Writing Group to Review New Evidence and Upda, S. B. King III, S. C. Smith Jr, J. W. Hirshfeld Jr, A. K. Jacobs, D. A. Morrison, and D. O. Williams
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
J. Am. Coll. Cardiol., January 15, 2008; 51(2): 172 - 209.
[Full Text] [PDF]


Home page
CirculationHome page
S. B. King III, S. C. Smith Jr, J. W. Hirshfeld Jr, A. K. Jacobs, D. A. Morrison, D. O. Williams, 2005 WRITING COMMITTEE MEMBERS, S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr, et al.
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee
Circulation, January 15, 2008; 117(2): 261 - 295.
[Full Text] [PDF]


Home page
JAMAHome page
D. M. Kent and R. A. Hayward
Limitations of Applying Summary Results of Clinical Trials to Individual Patients: The Need for Risk Stratification
JAMA, September 12, 2007; 298(10): 1209 - 1212.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol., August 14, 2007; 50(7): 652 - 726.
[Full Text] [PDF]


Home page
Emerg. Med. J.Home page
M. Karounos, A. M. Chang, J. L Robey, K. L Sease, F. S Shofer, C. Follansbee, and J. E Hollander
TIMI risk score: does it work equally well in both males and females?
Emerg. Med. J., July 1, 2007; 24(7): 471 - 474.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. T. Yan, R. T. Yan, M. Tan, A. Casanova, M. Labinaz, K. Sridhar, D. H. Fitchett, A. Langer, and S. G. Goodman
Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better
Eur. Heart J., May 1, 2007; 28(9): 1072 - 1078.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. J. Boos, S. K. Soor, D. Kang, and G. Y.H. Lip
Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes
Eur. Heart J., May 1, 2007; 28(9): 1092 - 1101.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Jeetley, L. Burden, B. Stoykova, and R. Senior
Clinical and economic impact of stress echocardiography compared with exercise electrocardiography in patients with suspected acute coronary syndrome but negative troponin: a prospective randomized controlled study
Eur. Heart J., January 16, 2007; (2007) ehl444v1.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. P. Marso, D. M. Safley, J. A. House, T. Tessendorf, K. J. Reid, and J. A. Spertus
Suspected Acute Coronary Syndrome Patients With Diabetes and Normal Troponin-I Levels Are at Risk for Early and Late Death: Identification of a new high-risk acute coronary syndrome population
Diabetes Care, August 1, 2006; 29(8): 1931 - 1932.
[Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
P. Jeetley, L. Burden, and R. Senior
Stress echocardiography is superior to exercise ECG in the risk stratification of patients presenting with acute chest pain with negative Troponin
Eur J Echocardiogr, March 1, 2006; 7(2): 155 - 164.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Glaser, H. A. Glick, H. C. Herrmann, and S. E. Kimmel
The Role of Risk Stratification in the Decision to Provide Upstream Versus Selective Glycoprotein IIb/IIIa Inhibitors for Acute Coronary Syndromes: A Cost-Effectiveness Analysis
J. Am. Coll. Cardiol., February 7, 2006; 47(3): 529 - 537.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
R.L. Soiza, S.J. Leslie, P. Williamson, S. Wai, K. Harrild, N.R. Peden, and A.D. Hargreaves
Risk stratification in acute coronary syndromes--does the TIMI risk score work in unselected cases?
QJM, February 1, 2006; 99(2): 81 - 87.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R Das, N Kilcullen, C Morrell, M B Robinson, J H Barth, A S Hall, and on behalf of the EMMACE-2 (evaluation of methods a
The British Cardiac Society Working Group definition of myocardial infarction: implications for practice
Heart, January 1, 2006; 92(1): 21 - 26.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G Devlin, F A Anderson, S Heald, J Lopez-Sendon, A Avezum, J Elliott, O H Dabbous, D Brieger, and for the GRACE Investigators
Management and outcomes of lower risk patients presenting with acute coronary syndromes in a multinational observational registry
Heart, November 1, 2005; 91(11): 1394 - 1399.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
N S Kleiman and H D White
The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromes
Heart, September 1, 2005; 91(9): 1121 - 1123.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S J Walsh, M S Spence, D Crossman, and A A J Adgey
Clopidogrel in non-ST segment elevation acute coronary syndromes: an overview of the submission by the British Cardiac Society and the Royal College of Physicians of London to the National Institute for Clinical Excellence, and beyond
Heart, September 1, 2005; 91(9): 1135 - 1140.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. de Araujo Goncalves, J. Ferreira, C. Aguiar, and R. Seabra-Gomes
TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS
Eur. Heart J., May 1, 2005; 26(9): 865 - 872.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C.-K. Wong and H. D. White
Value of community-derived risk models for stratifying patients with non-ST elevation acute coronary syndromes
Eur. Heart J., May 1, 2005; 26(9): 851 - 852.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
G A Large
Contemporary management of acute coronary syndrome
Postgrad. Med. J., April 1, 2005; 81(954): 217 - 222.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Garcia, M. J. Canoniero, J. A. Chirinos, E. de Marchena, T. Salerno, and A. Ferreira
Development of a Score to Predict the Need for Coronary Artery Bypass Graft Surgery in Patients With Non-ST Segment Elevation Acute Coronary Syndromes
Ann. Thorac. Surg., December 1, 2004; 78(6): 2022 - 2026.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. J. Popma, P. Berger, E. M. Ohman, R. A. Harrington, C. Grines, and J. I. Weitz
Antithrombotic Therapy During Percutaneous Coronary Intervention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 576S - 599S.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. D. Wiviott, D. A. Morrow, P. D. Frederick, R. P. Giugliano, C.M. Gibson, C. H. McCabe, C. P. Cannon, E. M. Antman, and E. Braunwald
Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: A simple index that predicts mortality in ST-segment elevation myocardial infarction
J. Am. Coll. Cardiol., August 18, 2004; 44(4): 783 - 789.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. A. Blazing, J. A. de Lemos, H. D. White, K. A. A. Fox, F. W. A. Verheugt, D. Ardissino, P. M. DiBattiste, J. Palmisano, D. W. Bilheimer, S. M. Snapinn, et al.
Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and Aspirin: A Randomized Controlled Trial
JAMA, July 7, 2004; 292(1): 55 - 64.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. S. Sabatine, D. A. Morrow, R. P. Giugliano, S. A. Murphy, L. A. Demopoulos, P. M. DiBattiste, W. S. Weintraub, C. H. McCabe, E. M. Antman, C. P. Cannon, et al.
Implications of Upstream Glycoprotein IIb/IIIa Inhibition and Coronary Artery Stenting in the Invasive Management of Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB Trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 Trial
Circulation, February 24, 2004; 109(7): 874 - 880.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Braunwald
Application of Current Guidelines to the Management of Unstable Angina and Non-ST-Elevation Myocardial Infarction
Circulation, October 21, 2003; 108(90161): III-28 - 37.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
W. S. Aronow
Review Article: Treatment of Unstable Angina Pectoris/Non-ST-Segment Elevation Myocardial Infarction in Elderly Patients
J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2003; 58(10): M927 - 933.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. P. Cannon and A. G.G. Turpie
Unstable Angina and Non-ST-Elevation Myocardial Infarction: Initial Antithrombotic Therapy and Early Invasive Strategy
Circulation, June 3, 2003; 107(21): 2640 - 2645.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. P. Cannon
Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: Insights from the TACTICS TIMI-18 trial
J. Am. Coll. Cardiol., February 19, 2003; 41(4_Suppl_S): 43S - 48S.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. S. Sabatine and E. M. Antman
The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction
J. Am. Coll. Cardiol., February 19, 2003; 41(4_Suppl_S): 89S - 95S.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Braunwald, E. M. Antman, J. W. Beasley, R. M. Califf, M. D. Cheitlin, J. S. Hochman, R. H. Jones, D. Kereiakes, J. Kupersmith, T. N. Levin, et al.
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina)
J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1366 - 1374.
[Full Text] [PDF]


Home page
CirculationHome page
E. Braunwald, E. M. Antman, J. W. Beasley, R. M. Califf, M. D. Cheitlin, J. S. Hochman, R. H. Jones, D. Kereiakes, J. Kupersmith, T. N. Levin, et al.
ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina)
Circulation, October 1, 2002; 106(14): 1893 - 1900.
[Full Text] [PDF]


Home page
CirculationHome page
C. P. Cannon
Evidence-Based Risk Stratification to Target Therapies in Acute Coronary Syndromes
Circulation, September 24, 2002; 106(13): 1588 - 1591.
[Full Text] [PDF]


Home page
CirculationHome page
A. Budaj, S. Yusuf, S. R. Mehta, K. A.A. Fox, G. Tognoni, F. Zhao, S. Chrolavicius, D. Hunt, M. Keltai, M. G. Franzosi, et al.
Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups
Circulation, September 24, 2002; 106(13): 1622 - 1626.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H. D. White and C. K. Wong
Risk stratification and treatment benefits in patients with non-ST-elevation acute coronary syndromes
Eur. Heart J., February 1, 2002; 23(3): 187 - 191.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.